2nd mover will always command less money than 1st mover and only a single phase 2 trial will have been completed - and the first approval for AD will be in the EU, not the US, so much less lucrative. I would be shocked if Anavex would not accept $14b b/o price if 2-73 is approved.
Market Data 
Markets 
AI
